Aspirin for primary prevention of coronary events.

被引:113
作者
Lauer, MS [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1056/NEJMcp012672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 45-year-old man with a strong family history of premature heart disease has no symptoms of coronary disease and has a normal electrocardiogram. A fasting lipid analysis reveals a total cholesterol level of 225 mg per deciliter (5.8 mmol per liter), a high-density lipoprotein cholesterol level of 35 mg per deciliter (0.9 mmol per liter), a triglyceride level of 150 mg per deciliter (1.7 mmol per liter), and a low-density lipoprotein cholesterol level of 160 mg per deciliter (4.1 mmol per liter). The man's resting systolic blood pressure is 125 mm Hg, and he has never taken any medications for hypertension. He is a nonsmoker and is physically active. Should he be advised to take aspirin to reduce his risk of coronary events?
引用
收藏
页码:1468 / 1474
页数:7
相关论文
共 52 条
[1]   Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].
Al-Khadra, AS ;
Salem, DN ;
Rand, WM ;
Udelson, JE ;
Smith, JJ ;
Konstam, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425
[2]   INFLAMMATION AND CORONARY-ARTERY DISEASE [J].
ALEXANDER, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07) :468-469
[3]  
[Anonymous], 1991, Ophthalmology, V98, P757
[4]  
[Anonymous], 1992, J MYOCARDIAL ISCHAEM
[5]   Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) :157-160
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]  
*CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716
[8]  
*CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506
[9]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[10]   Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis [J].
Derry, S ;
Loke, YK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7270) :1183-+